Xenoport Climbs as Investors Bet on Experimental Drug for MS – Minyanville.com

by admin on October 4, 2012

Xenoport Climbs as Investors Bet on Experimental Drug for MS
Minyanville.com
But the enthusiasm for the company has little to do with Xenoport's one existing product, Horizant (also known as Regnite), which is for restless leg syndrome as well as one other condition in the US. Rather, the shares are trading largely because of a
3 Stocks Near 52-Week Highs Worth SellingDailyFinance

all 3 news articles »

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: